Cited by 2,456Genetic factors in colorectal cancerColorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

The DOI matches its Crossref record; 218 of the 228 references it cites were found in a registry or an index.

Microsatellite Instability in Colorectal Cancer

Open access

Boland, C. Richard, Goel, Ajay·2010·Gastroenterology

DOI 10.1053/j.gastro.2009.12.064PMC PMC3037515

Open this paper in CoChat — free account

Abstract

Microsatellite instability (MSI) is a hypermutable phenotype caused by the loss of DNA mismatch repair activity. MSI is detected in about 15% of all colorectal cancers; 3% are of these are associated with Lynch syndrome and the other 12% are caused by sporadic, acquired hypermethylation of the promoter of the MLH1 gene, which occurs in tumors with the CpG island methylator phenotype. Colorectal tumors with MSI have distinctive features, including a tendency to arise in the proximal colon, lymphocytic infiltrate, and a poorly differentiated, mucinous or signet ring appearance. They have a slightly better prognosis than colorectal tumors without MSI and do not have the same response to chemotherapeutics. Discovery of MSI in colorectal tumors has increased awareness of the diversity of colorectal cancers and implications for specialized management of patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2009.12.064

Cites

218 of 218 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global cancer statistics
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Cancer statistics, 2012
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citation
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Self-citation

Show all 228 references

Sorted by citations

Items 301–400 of 1,002

Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis
Sakellariou, S., Fragkou, P., Levidou, G., Gargalionis, A. N., Piperi, C., Dalagiorgou, G., Adamopoulos, C., Saetta, A. A., Agrogiannis, G. D., Theohari, I., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2213-5 · Cited by 70
The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy
Ahn, S., Ansari, A. A., Kim, J., Kim, D., Chun, S., Kim, J., Kim, T. W., Park, I. J., Yu, C. S., & Jang, S. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11862 · Cited by 72
Clinical significance of microsatellite instability in colorectal cancer
Kloor, M., Staffa, L., Ahadova, A., & Doeberitz, M. V. K. (2013) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-013-1112-3 · Cited by 69
Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells
Shen, Y., Takahashi, M., Byun, H., Link, A., Sharma, N., Balaguer, F., Leung, H.-C., Boland, C. R., & Goel, A. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.19604 · Cited by 70
Self-citation
Immunoscore in mismatch repair‐proficient and ‐deficient colon cancer
Wirta, E., Seppälä, T. T., Friman, M., Väyrynen, J. P., Ahtiainen, M., Kautiainen, H., Kuopio, T., Kellokumpu, I., Mecklin, J., & Böhm, J. (2017) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.71 · Cited by 70
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation
Jacobs, J., Deschoolmeester, V., Zwaenepoel, K., Flieswasser, T., Deben, C., den Bossche, J. V., Hermans, C., Rolfo, C. D., Peeters, M., Wever, O. D., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1440167 · Cited by 69
Computed Tomography-Based Radiomic Features Could Potentially Predict Microsatellite Instability Status in Stage II Colorectal Cancer: A Preliminary Study
Fan, S., Li, X., Cui, X., Zheng, L. Z., Ren, X., Ma, W., & Ye, Z. (2019) · Academic Radiology · doi:10.1016/j.acra.2019.02.009 · Cited by 69
Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development
Sarogni, P., Palumbo, O., Servadio, A., Astigiano, S., D’Alessio, B., Gatti, V., Cukrov, D., Baldari, S., Pallotta, M. M., Aretini, P., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1116-0 · Cited by 66
Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target
Wang, H., Zhou, Y., Zhang, Y., Fang, S., Zhang, M., Li, H., Xu, F., Liu, L., Liu, J., Zhao, Q., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004302 · Cited by 69
Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration
Ubaid, S., Kushwaha, R., Kashif, M., & Singh, V. K. (2025) · Cancer Genetics · doi:10.1016/j.cancergen.2025.08.010 · Cited by 77
Implications of mismatch repair-deficient status on management of early stage colorectal cancer.
Kawakami, H., Zaanan, A., & Sinicrope, F. A. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.065 · Cited by 69
Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
Coyle, K. M., Boudreau, J. E., & Marcato, P. (2017) · BioMed Research International · doi:10.1155/2017/9620870 · Cited by 72
Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges
Yang, F., Wang, J., Wang, Y., Liu, B., & Molina, J. R. (2021) · Cancers · doi:10.3390/cancers14010109 · Cited by 73
Differential network analysis via lasso penalized D-trace loss
Yuan, H., Xi, R., Chen, C., & Deng, M. (2017) · Biometrika · doi:10.1093/biomet/asx049 · Cited by 68
DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression
Yang, C., Huang, H., Chang, Y., Lin, C., Lai, I., & Chang, J. (2016) · Oncology · doi:10.1159/000452281 · Cited by 68
Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review
An, Y., Zhou, J., Lin, G., Wu, H., Cong, L., Li, Y., Qiu, X., & Shi, W. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1609859 · Cited by 69
m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation
Chen, B., Hong, Y., Zhai, X., Deng, Y., Hu, H., Tian, S., Zhang, Y., Ren, X., Zhao, J., & Jiang, C. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06241-w · Cited by 76
Prognostic value of innate and adaptive immunity in colorectal cancer
Grizzi, F. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i2.174 · Cited by 67
Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies
Abedalthagafi, M. (2018) · Oncotarget · doi:10.18632/oncotarget.26249 · Cited by 67
Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability–High Colorectal Cancers
Sato, K., Kawazu, M., Yamamoto, Y., Ueno, T., Kojima, S., Nagae, G., Abe, H., Soda, M., Oga, T., Kohsaka, S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1574 · Cited by 65
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
Amodio, V., Mauri, G., Reilly, N. M., Bianchi, A. S., Siena, S., Bardelli, A., & Germano, G. (2021) · Cancers · doi:10.3390/cancers13112638 · Cited by 67
Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2
de Miranda, N. F. C. C., van Dinther, M., van den Akker, B. E. W. M., van Wezel, T., ten Dijke, P., & Morreau, H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.052 · Cited by 66
Molecular Pathways and Cellular Metabolism in Colorectal Cancer
Hagland, H. R., Berg, M., Jolma, I. W., Carlsen, A., & Søreide, K. (2013) · Digestive Surgery · doi:10.1159/000347166 · Cited by 67
The American College of Gastroenterology Emily Couric Lecture—The Adenoma–Carcinoma Sequence Revisited: Has the Era of Genetic Tailoring Finally Arrived?
Ahnen, D. J. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.423 · Cited by 66
MSIpred: a python package for tumor microsatellite instability classification from tumor mutation annotation data using a support vector machine
Wang, C., & Liang, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-35682-z · Cited by 68
Molecular features and gene expression signature of metastatic colorectal cancer (Review)
Poturnajova, M., Furielova, T., Balintova, S., Schmidtova, S., Kučerová, L., & Matúšková, M. (2021) · Oncology Reports · doi:10.3892/or.2021.7961 · Cited by 70
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
Carlsen, L., Huntington, K. E., & El‐Deiry, W. S. (2022) · Cancers · doi:10.3390/cancers14041028 · Cited by 67
Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression
Karagiannis, G. S., Musrap, N., Saraon, P., Treacy, A. D., Schaeffer, D. F., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0221 · Cited by 65
Update on Hereditary Colorectal Cancer
da Silva, F. C. C., Wernhoff, P., Dominguez‐Barrera, C., & Dominguez–Valentin, M. (2016) · Anticancer Research · doi:10.21873/anticanres.10983 · Cited by 64
Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancer
Masuda, K., Kornberg, A. E., Miller, J. D., Lin, S., Suek, N., Botella, T., Secener, K., Baccarella, A., Liang Cheng, C., Ingham, M. A., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.154646 · Cited by 66
Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology
Cohen, S. A., Pritchard, C. C., & Jarvik, G. P. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015406 · Cited by 64
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability
Borelli, B., Antoniotti, C., Carullo, M., Germani, M. M., Conca, V., & Masi, G. (2022) · Cancers · doi:10.3390/cancers14204974 · Cited by 62
Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
Piombino, C., Cortesi, L., Lambertini, M., Punie, K., Grandi, G., & Toss, A. (2020) · Journal of Oncology · doi:10.1155/2020/6384190 · Cited by 63
Development and validation of MRI‐based deep learning models for prediction of microsatellite instability in rectal cancer
Zhang, W., Yin, H., Huang, Z., Zhao, J., Zheng, H., He, D., Li, M., Tan, W., Tian, S., & Song, B. (2021) · Cancer Medicine · doi:10.1002/cam4.3957 · Cited by 63
Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection
Kamel, F., Eltarhoni, K., Nisar, P. J., & Soloviev, M. (2022) · Cancers · doi:10.3390/cancers14081889 · Cited by 65
Biomarkers of Response and Resistance to Immunotherapy in Microsatellite Stable Colorectal Cancer: Toward a New Personalized Medicine
Huyghe, N. D., Benidovskaya, E., Stevens, P., & den Eynde, M. V. (2022) · Cancers · doi:10.3390/cancers14092241 · Cited by 65
Colon Cancer: From Epidemiology to Prevention
Katsaounou, K., Nicolaou, E., Vogazianos, P., Brown, C., Stavrou, M., Teloni, S., Hatzis, P., Agapiou, A., Fragkou, E., Tsiaoussis, G. I., et al. (2022) · Metabolites · doi:10.3390/metabo12060499 · Cited by 65
Changes in cellular mechanical properties during onset or progression of colorectal cancer
Ciasca, G., Papi, M., Minelli, E., Palmieri, V., & Spirito, M. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i32.7203 · Cited by 62
P athogenic and targetable genetic alterations in 70 urachal adenocarcinomas
Reis, H., van der Vos, K. E., Niedworok, C., Herold, T., Módos, O., Szendrői, A., Hager, T., Ingenwerth, M., Vis, D. J., Behrendt, M. A., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31547 · Cited by 64
RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer
Maffeis, V., Nicolè, L., & Cappellesso, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01255 · Cited by 65
Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice
Fassan, M., Scarpa, A., Remo, A., Maglio, G. D., Troncone, G., Marchetti, A., Doglioni, C., Ingravallo, G., Perrone, G., Parente, P., et al. (2020) · Pathologica · doi:10.32074/1591-951x-158 · Cited by 64
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN
Codrich, M., Dalla, E., Mio, C., Antoniali, G., Malfatti, M. C., Marzinotto, S., Pierobon, M., Baldelli, E., Loreto, C. D., Damante, G., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01986-8 · Cited by 63
Mucin in cancer: a stealth cloak for cancer cells
Wi, D.-H., Cha, J., & Jung, Y. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.7.064 · Cited by 61
Tumour heterogeneity and evolutionary dynamics in colorectal cancer
Chan, D. K. H., & Buczacki, S. J. A. (2021) · Oncogenesis · doi:10.1038/s41389-021-00342-x · Cited by 62
The GA4GH Variation Representation Specification: A computational framework for variation representation and federated identification
Wagner, A. H., Babb, L. J., Alterovitz, G., Baudis, M., Brush, M., Cameron, D., Cline, M., Griffith, M., Griffith, O. L., Hunt, S. E., et al. (2021) · Cell Genomics · doi:10.1016/j.xgen.2021.100027 · Cited by 62
Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications
Zaanan, A., Meunier, K., Sangar, F., Fléjou, J., & Praz, F. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0024-x · Cited by 66
Effects of Fixation and Storage of Human Tissue Samples on Nucleic Acid Preservation
Nam, S. K., Im, J., Kwak, Y., Han, N., Nam, K. H., Seo, A. N., & Lee, H. S. (2014) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2014.48.1.36 · Cited by 62
Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma
Bu, X.-D. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i32.4089 · Cited by 62
Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency.
Yuan, L., Chi, Y., Chen, W., Chen, X., Wei, P., Sheng, W., Zhou, X., & Shi, D. (2015) · PubMed Central · Cited by 63
Biomarkers for Stratification in Colorectal Cancer: MicroRNAs
Fadaka, A. O., Pretorius, A., & Klein, A. (2019) · Cancer Control · doi:10.1177/1073274819862784 · Cited by 63
Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer
Hauptman, N., Skok, D. J., Spasovska, E., Boštjančič, E., & Glavač, D. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0501-z · Cited by 61
Current Microsatellite Instability Testing in Management of Colorectal Cancer
Sun, B. L. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.08.001 · Cited by 66
Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study
Höppener, D. J., Galjart, B., Nierop, P. M. H., Buisman, F. E., van der Stok, E. P., van den Braak, R. R. J. C., van Amerongen, M. J., Balachandran, V. P., Jarnagin, W. R., Kingham, T. P., et al. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab026 · Cited by 59
Deep Learning Approaches to Colorectal Cancer Diagnosis: A Review
Tamang, L. D., & Kim, B. W. (2021) · Applied Sciences · doi:10.3390/app112210982 · Cited by 62
Molecular markers for colon diagnosis, prognosis and targeted therapy
Herzig, D. O., & Tsikitis, V. L. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23806 · Cited by 63
Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability
Umeda, Y., Nagasaka, T., Mori, Y., Sadamori, H., Sun, D., Shinoura, S., Yoshida, R., Satoh, D., Nobuoka, D., Utsumi, M., et al. (2012) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-012-0531-9 · Cited by 61
Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
Zhang, C., Lv, J., Gong, L., Yu, L., Chen, X., Zhou, H., & Fan, L. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13090892 · Cited by 61
Microsatellite Instability Pathway and EMAST in Colorectal Cancer
Carethers, J. M. (2017) · Current Colorectal Cancer Reports · doi:10.1007/s11888-017-0352-y · Cited by 61
Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix
Jesinghaus, M., Konukiewitz, B., Foersch, S., Stenzinger, A., Steiger, K., Muckenhuber, A., Groß, C., Mollenhauer, M., Roth, W., Detlefsen, S., et al. (2018) · Modern Pathology · doi:10.1038/modpathol.2017.184 · Cited by 61
Historical perspective: Two decades of progress in treating metastatic colorectal cancer
Lee, R. M., Cardona, K., & Russell, M. C. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25431 · Cited by 62
The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients
Bohaumilitzky, L., Kluck, K., Hüneburg, R., Gallon, R., Nattermann, J., Kirchner, M., Kristiansen, G., Hommerding, O., Pfuderer, P. L., Wagner, L., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.11.029 · Cited by 58
Development and validation of a radiomics-based nomogram for the preoperative prediction of microsatellite instability in colorectal cancer
Ying, M., Pan, J., Lu, G., Zhou, S., Fu, J., Wang, Q., Wang, L., Hu, B., Wei, Y., & Shen, J. (2022) · BMC Cancer · doi:10.1186/s12885-022-09584-3 · Cited by 60
Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways
Hagland, H. R., & Søreide, K. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.026 · Cited by 59
Colorectal cancers choosing sides
Albuquerque, C. M., Bakker, E. R. M., van Veelen, W., & Smits, R. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.005 · Cited by 59
Down-Regulation of Dual-Specificity Phosphatase 5 in Gastric Cancer by Promoter CpG Island Hypermethylation and Its Potential Role in Carcinogenesis
Shin, S., Park, S.-Y., & Kang, G. H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.004 · Cited by 62
Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma
Shia, J. (2015) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2015.02.018 · Cited by 61
The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care
Rosa, M. D., Rega, D., Costabile, V., Duraturo, F., Niglio, A., Izzo, P., Pace, U., & Delrio, P. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16659790 · Cited by 61
Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer
Lee, S. A., Liu, F., Riordan, S. M., Lee, C. S., & Zhang, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00566 · Cited by 60
FANCJ suppresses microsatellite instability and lymphomagenesis independent of the Fanconi anemia pathwayPreprint
MATSUZAKI, K., Borel, V., Adelman, C. A., Schindler, D., & Boulton, S. J. (2015) · Genes & Development · doi:10.1101/gad.272740.115 · Cited by 58
Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer
Kaneta, A., Nakajima, S., Okayama, H., Matsumoto, T., Saito, K., Kikuchi, T., Endo, E., Ito, M., Mimura, K., Kanke, Y., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03200-w · Cited by 59
Boundaries, junctions and transitions in the gastrointestinal tract
Roman, A. K. S., & Shivdasani, R. A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.07.011 · Cited by 60
LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy
Lou, Y.-T., Chen, C., Fan, Y.-C., Chang, W., Lu, C., Wu, I., Hsu, W., Huang, C., & Wang, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123973 · Cited by 58
Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer
Burke, L., Butler, C. T., Murphy, A. G., Moran, B., Gallagher, W. M., O'Sullivan, J. N., & Kennedy, B. N. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00103 · Cited by 58
Tissue specificity of DNA damage response and tumorigenesis
Sun, S., Osterman, M. D., & Li, M. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0097 · Cited by 62
DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers
Bañobre, J. R., & Goel, A. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.071 · Cited by 58
Self-citation
Methylation-Based Therapies for Colorectal Cancer
Cervena, K., Siskova, A., Buchler, T., Vodicka, P., & Vymetalkova, V. (2020) · Cells · doi:10.3390/cells9061540 · Cited by 57
Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy
Vornholz, L., Isay, S. E., Kurgyis, Z., Strobl, D. C., Loll, P., Mosa, M. H., Luecken, M. D., Sterr, M., Lickert, H., Winter, C., et al. (2023) · Science Advances · doi:10.1126/sciadv.add8564 · Cited by 60
Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes
Pérot, P., Mullins, C. S., Naville, M., Bressan, C., Hühns, M., Gock, M. C., Kühn, F., Volff, J., Trillet-Lenoir, V. N., Linnebacher, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5539 · Cited by 57
Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge
Marmorino, F., Boccaccino, A., Germani, M. M., Falcone, A., & Cremolini, C. (2020) · Cancers · doi:10.3390/cancers12082317 · Cited by 58
Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer
Yang, Z., Wu, G., Zhang, X., Gao, J., Meng, C., Liu, Y., Wei, Q., Sun, L., Wei, P., Bai, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1001444 · Cited by 56
Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner
Udayasuryan, B., Zhou, Z., Ahmad, R. N., Sobol, P., Deng, C., Nguyen, T. T. D., Kodikalla, S., Morrison, R. G., Goswami, I., Slade, D. J., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06201-w · Cited by 59
Racial Diversity of Actionable Mutations in Non–Small Cell Lung Cancer
Bollig-Fischer, A. B., Chen, W., Gadgeel, S. M., Wenzlaff, A. S., Coté, M. L., Schwartz, A. G., & Bepler, G. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000420 · Cited by 56
Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer
Mohan, H. M., Ryan, É. J., Balasubramanian, I., Kennelly, R. P., Geraghty, R., Sclafani, F., Fennelly, D. W., McDermott, R., Ryan, É. J., O’Donoghue, D. P., et al. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2016.05.013 · Cited by 56
Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS
Wang, J., Yi, Y., Xiao, Y., Lin, D., Liang, L., Teng, L., Ying, J. M., Lu, T., Liu, Y., Guan, Y., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0212-1 · Cited by 56
Detection of Microsatellite Instability from Circulating Tumor DNA by Targeted Deep Sequencing
Cai, Z., Wang, Z., Liu, C., Shi, D., Li, D., Zheng, M., Han‐Zhang, H., Lizaso, A., Xiang, J., Lv, J., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.04.210 · Cited by 55
Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance
Ebrahimi, F., Gopalan, V., Wahab, R., Lu, C., Smith, R. A., & Lam, A. K.-Y. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.004 · Cited by 55
Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer
Han, S., Lee, H., Bae, J. M., Cho, N., Lee, K., Kim, T., Oh, D., Im, S., Bang, Y., Jeong, S., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27888 · Cited by 56
Precision medicine for metastatic colorectal cancer: an evolving era
Güler, İ., Aşkan, G., Klostergaard, J., & Şahin, İ. H. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1663174 · Cited by 56
BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis
Ju, Q., Li, X., Zhang, H., & Zhao, Y. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.573619 · Cited by 54
Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer
Wangefjord, S., Brändstedt, J., Lindquist, K. E., Nodin, B., Jirström, K., & Eberhard, J. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-10 · Cited by 55
Clinicopathological, genomic and immunological factors in colorectal cancer prognosis
Marks, K., West, N. P., Morris, E. J. A., & Quirke, P. (2018) · British journal of surgery · doi:10.1002/bjs.10756 · Cited by 54
Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer
Yang, L., Lei, Q., Li, L., Yang, J., Dong, Z., & Cui, H. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0778-y · Cited by 59
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers
Amato, M., Franco, R., Facchini, G., Addeo, R., Ciardiello, F., Berretta, M., Vita, G., Sgambato, A., Pignata, S., Caraglia, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158726 · Cited by 57
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Pavelescu, L. A., Enache, R. M., Roşu, O. A., Profir, M., Creţoiu, S. M., & Gașpar, B. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179659 · Cited by 59
Smoking Increases the Risk for Colorectal Adenomas in Patients With Lynch Syndrome
Winkels, R. M., Botma, A., van Duijnhoven, F. J. B., Nagengast, F. M., Kleibeuker, J. H., Vasen, H. F. A., & Kampman, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.033 · Cited by 53
Improving outcomes in colorectal cancer: Where do we go from here?
Cutsem, E. V., Borràs, J. M., Castells, A., Ciardiello, F., Ducreux, M. P., Haq, A., Schmoll, H., & Tabernero, J. M. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.026 · Cited by 57
Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients
Yanus, G. A., Belyaeva, A. V., Ivantsov, A. O., Kuligina, E. S., Suspitsin, E. N., Mitiushkina, N. V., Алексахина, С. Н., Iyevleva, A. G., Zaitseva, O. A., Yatsuk, O. S., et al. (2013) · Medical Oncology · doi:10.1007/s12032-013-0686-5 · Cited by 53
MSH3-Deficiency Initiates EMAST without Oncogenic Transformation of Human Colon Epithelial Cells
Campregher, C., Schmid, G., Ferk, F., Knasmüller, S., Khare, V., Kortüm, B., Dammann, K. W., Lang, M., Scharl, T., Spittler, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050541 · Cited by 53
Associations Between Colorectal Cancer Molecular Markers and Pathways With Clinicopathologic Features in Older Women
Samadder, N. J., Vierkant, R. A., Tillmans, L. S., Wang, A. H., Weisenberger, D. J., Laird, P. W., Lynch, C. F., Anderson, K. E., French, A. J., Haile, R. W., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.001 · Cited by 53
Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features
Wu, J., Cai, M., Li, S., Bei, J., Wang, F., Hampel, H., Ling, Y., Frayling, I. M., Sinicrope, F. A., Rodrı́guez-Bigas, M. A., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32044 · Cited by 53

Authors: Boland, C. R., & Goel, A.
Affiliations: Baylor University Medical Center (US)
Corresponding author: Boland, C. Richard
ORCID: Boland, C. Richard
Goel, Ajay
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2010-05
Volume: 138
Issue: 6
Pages: 2073-2087.e3
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2009.12.064
PMC: PMC3037515
OpenAlex: W2094390470
Cited by: 2,456
References: 228
Citations by year: 2026: 140 · 2025: 201 · 2024: 202 · 2023: 191 · 2022: 257 · 2021: 211 · 2020: 194 · 2019: 160 · 2018: 140 · 2017: 115 · 2016: 112 · 2015: 117 · 2014: 111 · 2013: 100 · 2012: 94
FWCI: 11.76
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (R01 CA129286, R01 CA72851)
National Cancer Institute
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords: microsatellite instability, colorectal cancer, DNA mismatch repair, Lynch syndrome, MLH1 promoter methylation, CpG island methylator phenotype, proximal colon tumors, lymphocyte infiltration, mucinous tumors, signet ring cell carcinoma, prognosis, chemotherapy response
MeSH terms: Animals, Cell Transformation, Neoplastic, Colorectal Neoplasms, Hereditary Nonpolyposis, Humans, Mutation, Phenotype, Risk Factors, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Treatment Outcome, Genetic Predisposition to Disease, Microsatellite Instability, DNA Mismatch Repair

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microsatellite Instability in Colorectal Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks